Narhex Life Sciences has made significant progress towards its ultimate goal of building a company based on the clinical and commercial success of therapeutic and diagnostic products which are used to manage patients with HIV infection.
"Continuing to progress the preclinical and clinical trials required for registration of our candidate anti-HIV drug and HIV Treatment Diagnostic ExaVir Load in China is now a key Narhex priority."